Revolution Medicines Inc
NASDAQ:RVMD
Revolution Medicines Inc
Other Liabilities
Revolution Medicines Inc
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Revolution Medicines Inc
NASDAQ:RVMD
|
Other Liabilities
$88.5m
|
CAGR 3-Years
32%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Liabilities
$32.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Liabilities
$3.4B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
24%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Liabilities
$6.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
0%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Liabilities
$1.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
51%
|
CAGR 10-Years
33%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Liabilities
$1.1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
18%
|
See Also
What is Revolution Medicines Inc's Other Liabilities?
Other Liabilities
88.5m
USD
Based on the financial report for Dec 31, 2023, Revolution Medicines Inc's Other Liabilities amounts to 88.5m USD.
What is Revolution Medicines Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
23%
Over the last year, the Other Liabilities growth was 53%. The average annual Other Liabilities growth rates for Revolution Medicines Inc have been 32% over the past three years , 23% over the past five years .